Literature DB >> 33580752

TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks.

Kacie D Deters1, Elizabeth C Mormino1, Lei Yu2, Michael W Lutz3, David A Bennett2, Lisa L Barnes2.   

Abstract

INTRODUCTION: The goal was to investigate effects of APOE-TOMM40-'523 haplotypes on cognitive decline in non-demented non-Hispanic Blacks (NHB), and determine whether effects differ from non-Hispanic Whites (NHW).
METHODS: The impact of zero to two copies of the '523-Short variant (S; poly-T alleles < 20) within apolipoprotein E (APOE) genotype on a composite measure of global cognition and five domains was examined.
RESULTS: In NHB with ε3/ε3 (N = 294), '523-S/S was associated with faster decline in global cognition (β = -0.048, P = 0.017), episodic memory (β = -0.05, P = 0.031), and visuospatial ability (β = -0.037, P = 0.034) relative to those without '523-S. For NHB ε4+ (N = 182), '523-S/S had slower decline in global cognition (β = 0.047, P = 0.042) and visuospatial ability (β = 0.07, P = 0.0005) relative to '523-S non-carriers. NHB ε4+ with '523-S also had a slower rate of decline than NHWs ε4+ with '523-S. DISCUSSION: '523-S/S has a different effect on cognitive decline among NHB dependent on APOE allele. Differences in the effect of ε4-'523-S in NHB may explain prior mixed findings on ε4 and decline in this population.
© 2021 the Alzheimer's Association.

Entities:  

Keywords:  cognitive aging; cohort studies; genetics; memory

Mesh:

Substances:

Year:  2021        PMID: 33580752      PMCID: PMC8855738          DOI: 10.1002/alz.12295

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  36 in total

1.  Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

Authors:  Chang-En Yu; Howard Seltman; Elaine R Peskind; Nichole Galloway; Peter X Zhou; Elisabeth Rosenthal; Ellen M Wijsman; Debby W Tsuang; Bernie Devlin; Gerard D Schellenberg
Journal:  Genomics       Date:  2007-04-16       Impact factor: 5.736

2.  The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia.

Authors:  Lisa L Barnes; Raj C Shah; Neelum T Aggarwal; David A Bennett; Julie A Schneider
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

3.  Race, APOEɛ4, and Long-Term Cognitive Trajectories in a Biracial Population Sample.

Authors:  Kumar B Rajan; Elizabeth A McAninch; Robert S Wilson; Jennifer Weuve; Lisa L Barnes; Denis A Evans
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  Differences in prevalence of and risk factors for subclinical vascular disease among black and white participants in the Cardiovascular Health Study.

Authors:  L Kuller; L Fisher; R McClelland; L Fried; M Cushman; S Jackson; T Manolio
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-02       Impact factor: 8.311

5.  TOMM40'523 variant and cognitive decline in older persons with APOE ε3/3 genotype.

Authors:  Lei Yu; Michael W Lutz; Robert S Wilson; Daniel K Burns; Allen D Roses; Ann M Saunders; Chris Gaiteri; Philip L De Jager; Lisa L Barnes; David A Bennett
Journal:  Neurology       Date:  2017-01-20       Impact factor: 9.910

6.  Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults.

Authors:  Kathryn Sawyer; Natalie Sachs-Ericsson; Kristopher J Preacher; Dan G Blazer
Journal:  Gerontology       Date:  2008-06-05       Impact factor: 5.140

7.  Longitudinal modeling of cognitive aging and the TOMM40 effect.

Authors:  Richard J Caselli; Amylou C Dueck; Matthew J Huentelman; Michael W Lutz; Ann M Saunders; Eric M Reiman; Allen D Roses
Journal:  Alzheimers Dement       Date:  2012-11       Impact factor: 21.566

8.  Apolipoprotein E and change in episodic memory in blacks and whites.

Authors:  L L Barnes; Z Arvanitakis; L Yu; J Kelly; P L De Jager; D A Bennett
Journal:  Neuroepidemiology       Date:  2013-01-24       Impact factor: 3.282

9.  APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.

Authors:  Lei Yu; Michael W Lutz; Robert S Wilson; Daniel K Burns; Allen D Roses; Ann M Saunders; Jingyun Yang; Chris Gaiteri; Philip L De Jager; Lisa L Barnes; David A Bennett
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

10.  Use of local genetic ancestry to assess TOMM40-523' and risk for Alzheimer disease.

Authors:  Parker L Bussies; Farid Rajabli; Anthony Griswold; Daniel A Dorfsman; Patrice Whitehead; Larry D Adams; Pedro R Mena; Michael Cuccaro; Jonathan L Haines; Goldie S Byrd; Gary W Beecham; Margaret A Pericak-Vance; Juan I Young; Jeffery M Vance
Journal:  Neurol Genet       Date:  2020-03-03
View more
  1 in total

1.  TOMM40 genetic variants associated with healthy aging and longevity: a systematic review.

Authors:  Sunny Chen; Sara M Sarasua; Nicole J Davis; Jane M DeLuca; Luigi Boccuto; Stephen M Thielke; Chang-En Yu
Journal:  BMC Geriatr       Date:  2022-08-13       Impact factor: 4.070

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.